Cargando…

Diabetes Mellitus and Poorer Prognosis in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

BACKGROUND: Previous studies suggested that diabetes mellitus was associated with cancer risk and prognosis, but studies investigating the relationship between diabetes mellitus and survival in patients with hepatocellular carcinoma (HCC) reported inconsistent findings. To derive a more precise esti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yan-Gang, Wang, Peng, Wang, Bin, Fu, Zheng-Ju, Zhao, Wen-Juan, Yan, Sheng-Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022589/ https://www.ncbi.nlm.nih.gov/pubmed/24830459 http://dx.doi.org/10.1371/journal.pone.0095485

Ejemplares similares

Poorer Prognosis of Primary Signet-Ring Cell Carcinoma of the Breast Compared with Mucinous Carcinoma
por: Wu, Xiufeng, et al.
Publicado: (2016)

Subphrenic Lymph Node Metastasis Predicts Poorer Prognosis for Nasopharyngeal Carcinoma Patients With Metachronous Metastasis
por: Zhang, Xue-Fang, et al.
Publicado: (2021)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
por: Miura, Seiki, et al.
Publicado: (2012)

INHBA upregulation correlates with poorer prognosis in patients with esophageal squamous cell carcinoma
por: Lyu, Shanshan, et al.
Publicado: (2018)

Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
por: He, Wei, et al.
Publicado: (2009)

CCAAT/enhancer binding protein α predicts poorer prognosis and prevents energy starvation–induced cell death in hepatocellular carcinoma
por: Lu, Guo-Dong, et al.
Publicado: (2015)

Diabetes Mellitus and Risk of Hepatocellular Carcinoma
por: Li, Xu, et al.
Publicado: (2017)

Lower Education and Household Income Contribute to Advanced Disease, Less Treatment Received and Poorer Prognosis in Patients with Hepatocellular Carcinoma
por: Shen, Yuan, et al.
Publicado: (2017)

Down-regulation of solute carrier family 10 member 1 is associated with early recurrence and poorer prognosis of hepatocellular carcinoma
por: Tran, Quynh Hoa, et al.
Publicado: (2021)

Clear Cell Adenocarcinoma of the Urinary Bladder Is a Glycogen-Rich Tumor with Poorer Prognosis
por: Zhou, Zhengqiu, et al.
Publicado: (2020)

Microvascular invasion (MVI) is a poorer prognostic predictor for small hepatocellular carcinoma
por: Du, Min, et al.
Publicado: (2014)

Glycogen Synthase Kinase-3β Is Associated with the Prognosis of Hepatocellular Carcinoma and May Mediate the Influence of Type 2 Diabetes Mellitus on Hepatocellular Carcinoma
por: Qiao, Guoliang, et al.
Publicado: (2014)

Patients with diabetes mellitus experience poorer outcomes after arthroscopic rotator cuff repair
por: Sayegh, Eli T., et al.
Publicado: (2021)

The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies
por: Yang, Wan-Shui, et al.
Publicado: (2011)

Poorer prognosis in patients with advanced gastric squamous cell carcinoma compared with adenocarcinoma of the stomach: Case report
por: Meng, Ying, et al.
Publicado: (2017)

Overexpression of SLC38A1 is associated with poorer prognosis in Chinese patients with gastric cancer
por: Xie, Jing, et al.
Publicado: (2014)

Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma
por: Zhu, Qian, et al.
Publicado: (2015)

Upregulation of MYBL2 independently predicts a poorer prognosis in patients with clear cell renal cell carcinoma
por: Sun, Shan-Shan, et al.
Publicado: (2020)

Postoperative aspartate aminotransferase to platelet ratio index change predicts prognosis for hepatocellular carcinoma
por: Peng, Wei, et al.
Publicado: (2016)

Screening for Gestational Diabetes Mellitus: Are Guidelines From High-Income Settings Applicable to Poorer Countries?
por: Utz, Bettina, et al.
Publicado: (2015)

Predicting Prognosis of Hepatocellular Carcinoma Patients Based on the Expression Signatures of Mitophagy Genes
por: Li, Yan-ke, et al.
Publicado: (2022)

Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation
por: Shan, Yuhua, et al.
Publicado: (2017)

MLH1 promoter hypermethylation predicts poorer prognosis in mismatch repair deficiency endometrial carcinomas
por: Kaneko, Enami, et al.
Publicado: (2021)

Malignant Melanoma in the Elderly: Different Regional Disease and Poorer Prognosis
por: Macdonald, James B., et al.
Publicado: (2011)

Initial misdiagnosis of melanoma located on the foot is associated with poorer prognosis
por: Sondermann, Wiebke, et al.
Publicado: (2016)

Gut dysbiosis is associated with poorer long-term prognosis in cirrhosis
por: Maslennikov, Roman, et al.
Publicado: (2021)

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma
por: Fu, Shun-Jun, et al.
Publicado: (2018)

Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma
por: Zheng, Ju-Yan, et al.
Publicado: (2022)

Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis
por: Jiang, Chuan, et al.
Publicado: (2022)

The Impact of Diabetes Mellitus on Renal Cell Carcinoma Prognosis: A Meta-Analysis of Cohort Studies
por: Chen, Luyao, et al.
Publicado: (2015)

High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma
por: Xu, Yi, et al.
Publicado: (2016)

Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
por: Wen, Wei-Lun, et al.
Publicado: (2022)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma
por: Xia, Hai-Bing, et al.
Publicado: (2018)

Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer
por: Ma, Yu-Teng, et al.
Publicado: (2018)

Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma
por: Li, Tao, et al.
Publicado: (2016)

Impact of diabetes mellitus on the risk and survival of nasopharyngeal carcinoma: a meta-analysis
por: Guo, Gang, et al.
Publicado: (2018)

Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma: A meta-analysis
por: He, Chao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ftj9mabp51fho2vndnn4mbhcba